| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K48334597 |
| PharmacoGx | BRD-K48334597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RSPO4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | CNOT4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | RP11-468E2.6 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | UNC5B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | ADRB1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | CHODL | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | DNAJC5B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | NPHS2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | OR10R2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | LMO1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
